Faculty Disclosures
All speakers, moderators, and planning committee members involved in an AST educational activity (live or electronic) must disclose any and all relevant financial relationships* of any amount occurring within the past 12 months that they or their spouse/partner have with any commercial interest, defined as an entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. *A relevant financial relationship means the relationship(s) creates a potential conflict of interest relevant to the content of the educational activity. Any real or perceived conflict of interest must be resolved prior to finalizing the program. Speakers must also disclose any off label uses of any products they may mention during their presentation.
The AST Conflict of Interest (COI) Committee is responsible for reviewing all disclosures of potential conflicts of interest made by speakers, moderators, and planning committee members. The COI Committee must determine for each reported relationship whether or not that relationship represents an actual conflict of interest relevant to the content of the educational activity, or represents no conflict of interest. If a relationship is found to represent an actual conflict of interest, steps must be taken to resolve/remove the potential conflict of interest. Possible resolutions include altering the nature of the faculty member's relationship with the commercial interest, altering the content of the presentation, or replacing the faculty member.
Reported disclosures and resolutions (if applicable) are displayed below for all AST educational activities; faculty with no reported financial relationships are listed as having no relationships to disclose. Each speaker must also include a disclosure notification at the start of his/her activity and accompany the visual notification with a verbal disclosure if possible; faculty with no reported financial relationships must indicate that they have no relationships to disclose. Additionally, all educational activities will be systematically surveyed for audience perception of bias as part of the post-activity evaluation. Moderators will also be asked to provide feedback from their sessions.
If you have concerns about a conflict of interest related issue, please contact AST staff at info@myAST.org to reach the Conflict of Interest Committee.
Timely Topics in Transplantation Webinar Series 2014-2015
Timely Topics in Transplantation Webinar Series 2013-2014
Fellows Live Webinar Series 2013-2014
Business of Transplantation Webinar Series 2014
Activity: Timely Topics in Transplantation Webinar Series 2014-2015
Name | Role | Topic | Disclosure of Relevant Financial Relationships | Resolution |
---|---|---|---|---|
Gena Boyle, MPA | Speaker | Kidney Allocation System Changes | Nothing to disclose | N/A |
Kim Brown, MD | Speaker | Update on Hepatitis C Eradication Including Renal Clearance and Dosing and Important DDI Highlights | Consultant: Blue Cross Transplant Centers of Distinction, Vertex, Genentech, Salix, Merck, Janssen Grant support: Mass Biologics, Merck, CDC Foundation Speakers' bureau: HCV Viewpoints, Gilead |
No conflicts exist |
Robert Brown, MD | Moderator | Hepatitis C Treatment in Non-liver Solid Organ Transplant Recipients | Grant support: Novartis | No conflict exists |
Lara Danziger-Isakov, MD, MPH | Speaker | Vaccine Updates in SOT: What's New, What's Standard of Care? | Nothing to disclose | N/A |
Richard Formica, MD | Speaker | Kidney Allocation System Changes | Committee member: UNOS Co-investigator: Alexion Advisory Board: BMS |
No conflict exists |
John Friedewald, MD | Speaker | Multiorgan Transplantation: One Organ Too Many? | Nothing to disclose | N/A |
Catherine Garvey, RN, BA, CCTC | Moderator | Medically Complex Living Donors: Candidacy, Care, and Informed Consent | Nothing to disclose | N/A |
Elisa Gordon, PhD, MPH | Speaker | Medically Complex Living Donors: Candidacy, Care, and Informed Consent | Nothing to disclose | N/A |
Peter Heeger, MD | Speaker | Monitoring the Alloresponse Before and After Transplantation | Nothing to disclose | N/A |
Atul Humar, MD | Speaker | Cytomegalovirus: Prevention, Therapy, Immunity | Consultant: Astellas, Chimerix Grant support: Roche |
No conflict exists |
Shirish Huprikar, MD | Moderator | Cytomegalovirus: Prevention, Therapy, Immunity | Consultant: Oxford Immunotec, Sunshine Heart Grant support: Astellas |
No conflict exists |
Tiffany Kaiser, PharmD | Speaker | Update on Hepatitis C Eradication Including Renal Clearance and Dosing and Important DDI Highlights | Nothing to disclose | N/A |
Jon Kobashigawa, MD | Speaker | Treatment of Antibody-mediated Rejection in Thoracic Transplants |
Grant support: Novartis, CareDx, Inc. |
No conflict exists |
Camille Kotton, MD | Speaker | Cytomegalovirus: Prevention, Therapy, Immunity | Consultant: Roche, Merck, Astellas, Cellestis, Oxford Immunotec | No conflict exists |
Deepali Kumar, MD | Speaker | Vaccine Updates in SOT: What's New, What's Standard of Care? | Grant support: Roche, GlaxoSmithKline Speakers' bureau: Pfizer, Merck Consultant: Oxford Immunotec, Roche Unrestricted research grant: Astellas Research materials: Qiagen |
No conflict exists |
Josh Levitsky, MD | Moderator | Update on Hepatitis C Eradication Including Renal Clearance and Dosing and Important DDI Highlights | Consultant: Transplant Genomics, Inc., Abbvie Speaker's Bureau: Gilead, Salix |
No conflict exists |
Matt Morrell, MD | Speaker | Treatment of Antibody-mediated Rejection in Thoracic Transplants | Nothing to disclose | N/A |
Thomas Mueller, MD, PhD | Speaker | World Transplant Congress 2014: Clinical Highlights | Nothing to disclose | N/A |
Christian Oberkofler, MD | Speaker | World Transplant Congress 2014: Clinical Highlights | Nothing to disclose | N/A |
Raymund Razonable, MD | Speaker | Cytomegalovirus: Prevention, Therapy, Immunity | Nothing to disclose | N/A |
Peter Reese, MD, MSCE | Speaker | Multiorgan Transplantation: One Organ Too Many? | Nothing to disclose | N/A |
Leonardo Riella, MD, PhD | Moderator | Monitoring the Alloresponse Before and After Transplantation | Nothing to disclose | N/A |
David Serur, MD | Speaker | Medically Complex Living Donors: Candidacy, Care, and Informed Consent | Awaiting disclosure | TBD |
Norah Terrault, MD, MPH | Speaker | Hepatitis C Treatment in Non-liver Solid Organ Transplant Recipients | Nothing to disclose | N/A |
Jason Wertheim, MD | Moderator | Multiorgan Transplantation: One Organ Too Many? | Honorarium: Center for the Advancement of Science in Space, Provincial Health Services Authority Grant Support: NIH/NIDDK, ASTS, NKF Illinois, AASLD Stipent: Landes Bioscience |
No conflict exists |
Julie Yabu, MD | Moderator | Treatment of Antibody-mediated Rejection in Thoracic Transplants | Consultant (one-time): CareDx | No conflict exists |
Activity: Timely Topics in Transplantation Webinar Series 2013-2014
Activity: Fellows Live Webinar Series 2013-2014
Name | Role | Topic | Disclosure of Relevant Financial Relationships | Resolution |
---|---|---|---|---|
Yolanda Becker, MD | Speaker | Ethics in Transplantation | Nothing to disclose | N/A |
David Wojciechowski, DO | Speaker | Ethics in Transplantation | Nothing to disclose | N/A |
Naima Carter-Monroe, MD | Speaker | Pathology | Nothing to disclose | N/A |
Lorraine Racusen, MD | Speaker | Pathology | Nothing to disclose | N/A |
E. Rene Rodriguez, MD | Speaker | Pathology | Nothing to disclose | N/A |
Nitika Gupta, MD | Speaker | Pathology | Nothing to disclose | N/A |
Murli Krishna, MD | Speaker | Pathology | Nothing to disclose | N/A |
Jamil Azzi, MD | Speaker | Future of Translational Research | Nothing to disclose | N/A |
Leonardo Riella, MD, PhD | Speaker | Future of Translational Research | Grant Support: American Heart Association | No conflict exists |
Peter Heeger, MD | Speaker | Future of Translational Research | Nothing to disclose | N/A |
Nicole Theodoropoulos, MD | Speaker | Should I Accept this Donor? | Nothing to disclose | N/A |
Michael Ison, MD | Speaker | Should I Accept this Donor? | Nothing to disclose | N/A |
Dorry Segev, MD | Speaker | Should I Accept this Donor? | Nothing to disclose | N/A |
Rita Alloway, PharmD | Speaker | Generic Immunosuppressants | Grant Support: Astellas, Alexion, BMS Consultant: Up-to-Date |
No conflict exists |
Simon Tremblay, PharmD | Speaker | Generic Immunosuppressants | Nothing to disclose | N/A |
Manjushree Gautam, MD | Speaker | Malignancies after Solid Organ Transplantation | Nothing to disclose | N/A |
John Gill, MD | Speaker | Malignancies after Solid Organ Transplantation | Nothing to disclose | N/A |
Activity: Business of Transplantation Webinar Series 2014
Name | Role | Topic | Disclosure of Relevant Financial Relationships | Resolution |
---|---|---|---|---|
Jesse Schold, PhD, MStat, MEd | Speaker | Understanding CUSUM and Bayesian Charts: New SRTR Transplant Reporting Methodologies | Nothing to disclose | N/A |
Lisa Stocks, RN, MSN, FNP | Speaker | OPO Quality Program | Nothing to disclose | N/A |
Kevin Myer, MSHA | Speaker | OPO and Transplant Center Collaborations | Nothing to disclose | N/A |
William Vaughan | Speaker | OPO Finance | Consultant: Guidry & East | |
Jon Friedman, MD | Speaker | Optum | Nothing to disclose | N/A |
Patricia Martin, RN, BSN | Speaker | WellPoint, Inc. | Nothing to disclose | N/A |
Thomas Hamilton, MA | Speaker | Centers for Medicare and Medicaid Services | Nothing to disclose | N/A |
Donate
Donate
Career Center
Career Center
Patient Education
Patient Education
Educational Content Disclaimer: The content, information, opinions, and viewpoints contained in educational materials housed on and linked from the AST web site are those of the authors or contributors of such materials. While the AST and its committees take great care to screen the credentials of the contributors and make every attempt to review the contents, AST MAKES NO WARRANTY, EXPRESSED OR IMPLIED, as to the completeness or accuracy of the content contained in the educational materials or on this website. The reader of these materials uses these materials at his or her own risk, and AST shall not be responsible for any errors, omissions, or inaccuracies in these materials, whether arising through negligence, oversight, or otherwise. Reliance on any information appearing on this site is strictly at your own risk. Read the full disclaimer.